Published November 2015 | Version v1
Miscellaneous

Impact and advantages of PET/CT when partnered with Ra -223 Therapy

  • 1. Department of Nuclear Medicine, Sirio Libanês Hospital, Sao Paulo (Brazil)

Description

Fluoride PET/CT skeletal tumor burden can be used as an imaging bio marker of OS, BMF and of the risk of a bone event in CRP C patients treated with Ra-223

Part of:
Conferences [25. Alasbimn Congress 2015; 5. Subimn congress; 2. latinamerican meeting of radiochemical]

Additional details

Additional titles

Original title (English)
Conferencias [25. Congreso Alasbimn 2015; 5o. congreso de la SUBUMN; 2o. encuentro latinoamericano de radiofarmacia]

Publishing Information

Imprint Place
Punta del Este (Uruguay)
Imprint Title
Conferences [25. Alasbimn Congress 2015; 5. Subimn congress; 2. Latin-American meeting of radiochemical]
Imprint Pagination
1 p.
Journal Page Range
34 p.
Report number
INIS-UY-GEO--700

Conference

Title
25. Alasbimn Congress 2015; 5. Subimn congress; 2. Latin-American meeting of radiochemical
Original Conference Title
25. Congreso Alasbimn 2015
Dates
18-21 Nov 2015
Place
Punta del Este (Uruguay)

Optional Information

Notes
Imprint:Conferencias [25. Congreso Alasbimn 2015; 5o. congreso de la SUBUMN; 2o. encuentro latinoamericano de radiofarmacia]